ATE323693T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents

Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Info

Publication number
ATE323693T1
ATE323693T1 AT01981239T AT01981239T ATE323693T1 AT E323693 T1 ATE323693 T1 AT E323693T1 AT 01981239 T AT01981239 T AT 01981239T AT 01981239 T AT01981239 T AT 01981239T AT E323693 T1 ATE323693 T1 AT E323693T1
Authority
AT
Austria
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
AT01981239T
Other languages
English (en)
Inventor
Bipinchandra Chaudhari
Marc Chapdelaine
Greg Hostetler
Lucius Kemp
John Mccauley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE323693T1 publication Critical patent/ATE323693T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01981239T 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen ATE323693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
ATE323693T1 true ATE323693T1 (de) 2006-05-15

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Country Status (9)

Country Link
US (1) US6815447B2 (de)
EP (1) EP1339706B1 (de)
JP (1) JP2004513125A (de)
AT (1) ATE323693T1 (de)
AU (1) AU2002212894A1 (de)
DE (1) DE60118956T2 (de)
ES (1) ES2261496T3 (de)
SE (1) SE0004053D0 (de)
WO (1) WO2002036586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
CA2486376A1 (en) 2002-05-22 2003-12-04 Amgen Inc. Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
BR0313255A (pt) 2002-08-08 2005-07-12 Amgen Inc Composto, composição farmacêutica, uso de um composto e métodos de fabricar um medicamento e de preparar um composto
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
US7423148B2 (en) 2002-11-21 2008-09-09 Chiron Corporation Small molecule PI 3-kinase inhibitors and methods of their use
US7517890B2 (en) * 2003-11-20 2009-04-14 Children's Hospital Medical Center GTPase inhibitors and methods of use
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
EP1871372A4 (de) * 2005-04-08 2010-06-02 Neuromed Pharmaceuticals Ltd Kombinationstherapie mit einem calciumkanalblocker vom n-typ zur schmerzminderung
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
US8362021B2 (en) * 2006-05-11 2013-01-29 Zalicus Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
CA2675558A1 (en) 2007-02-06 2008-08-14 Novartis Ag Pi 3-kinase inhibitors and methods of their use
KR101761963B1 (ko) * 2010-03-04 2017-07-26 머크 샤프 앤드 돔 코포레이션 카테콜 o-메틸 트랜스퍼라제의 억제제 및 정신병적 장애의 치료에서의 그의 용도
ES2862931T3 (es) 2010-03-04 2021-10-08 Merck Sharp & Dohme Inhibidores de la catecol O-metil transferasa y su uso en el tratamiento de trastornos psicóticos
AU2011223976B2 (en) 2010-03-04 2015-05-21 Merck Sharp & Dohme Corp. Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
WO2012122279A1 (en) 2011-03-08 2012-09-13 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
JP6026544B2 (ja) 2011-09-27 2016-11-16 ノバルティス アーゲー 変異体idhの阻害剤としての3−ピリミジン−4−イル−オキサゾリジン−2−オン類
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
MX355945B (es) 2013-03-14 2018-05-07 Novartis Ag 3-pirimidin-4-il-oxazolidin-2-onas como inhibidoras de idh mutante.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
NZ507760A (en) 1998-03-26 2002-10-25 Japan Tobacco Inc Amide derivatives and nociceptin antagonists

Also Published As

Publication number Publication date
US20040058945A1 (en) 2004-03-25
AU2002212894A1 (en) 2002-05-15
WO2002036586A1 (en) 2002-05-10
ES2261496T3 (es) 2006-11-16
DE60118956D1 (de) 2006-05-24
EP1339706A1 (de) 2003-09-03
US6815447B2 (en) 2004-11-09
JP2004513125A (ja) 2004-04-30
SE0004053D0 (sv) 2000-11-06
DE60118956T2 (de) 2007-03-15
EP1339706B1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60204232D1 (de) Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
IS6658A (is) Ný efnasambönd
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
ATE284690T1 (de) Antithrombotische diamine
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
DE60035057D1 (de) CD40 Antagonist zur Behandlung von Psoriasis
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
SE0302139D0 (sv) Novel compounds
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
YU13301A (sh) Muskarinski agonisti i antagonisti
SE0003476D0 (sv) Compounds
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
SE0303280D0 (sv) Novel compounds
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE60137534D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
SE9802209D0 (sv) Novel compounds
SE0302755D0 (sv) Novel compounds
EA200300556A1 (ru) Композиция n-(метилэтиламинокарбонил)-4-(3-метилфениламино)-3-пиридилсульфонамида и циклических олигосахаридов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties